These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


295 related items for PubMed ID: 17917551

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A case of hyperammonaemic encephalopathy due to valproic acid.
    Prins MC, van Meijel JJ.
    Neth J Med; 2011 Sep; 69(9):389-91. PubMed ID: 21978982
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A case of valproate-induced hyperammonaemic encephalopathy.
    Lucie O, Nazir F, Spilg E.
    Scott Med J; 2013 Feb; 58(1):e43-4. PubMed ID: 23596040
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
    Rigamonti A, Lauria G, Grimod G, Bianchi G, Salmaggi A.
    J Clin Neurosci; 2014 Apr; 21(4):690-1. PubMed ID: 24119342
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Valproate-induced hyperammonemia in mental retardation: a case report and review of the literature.
    Khoo CL, Naik S, Lua R, Chai SB, Liew A, Sim K.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr 16; 34(3):561-2. PubMed ID: 20184937
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Severe hyperammonaemic encephalopathy resulting from the overlap between hepatic and valproate encephalopathy.
    Izadi Firouzabadi L, Geer K, Mead P, Paul Mead.
    Postgrad Med J; 2018 Nov 16; 94(1117):664. PubMed ID: 30397004
    [No Abstract] [Full Text] [Related]

  • 18. Valproate induced non hepatic hyperammonaemic encephalopathy (VNHE)--a study from tertiary care referral university hospital, north India.
    Mehndiratta MM, Mehndiratta P, Phul P, Garg S.
    J Pak Med Assoc; 2008 Nov 16; 58(11):627-31. PubMed ID: 19024136
    [Abstract] [Full Text] [Related]

  • 19. [Valproate-caused encephalopathy].
    Thygesen KS, Wolf P.
    Ugeskr Laeger; 2005 Oct 03; 167(40):3793-4. PubMed ID: 16221398
    [Abstract] [Full Text] [Related]

  • 20. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
    Panda S, Radhakrishnan K.
    J Assoc Physicians India; 2004 Sep 03; 52():746-8. PubMed ID: 15839456
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.